CDKN2A and neoplasm: Specifically, using array comparative genomic hybridisation and fluorescence in situ hybridisation, we have shown that INK4A/ARF is selectively deleted from >90% of tumour cell nuclei of supratentorial ependymomas but is rarely deleted from tumours arising in other regions of the CNS (Taylor et al, 2005).